PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

Here we aim to provide updated guidance and standards for the indication, acquisition, and interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics are reported for a variety of available PSMA small radioligands. Different scenarios for the clinical use of PSMA-ligan...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of nuclear medicine and molecular imaging Vol. 50; no. 5; pp. 1466 - 1486
Main Authors Fendler, Wolfgang P., Eiber, Matthias, Beheshti, Mohsen, Bomanji, Jamshed, Calais, Jeremie, Ceci, Francesco, Cho, Steve Y., Fanti, Stefano, Giesel, Frederik L., Goffin, Karolien, Haberkorn, Uwe, Jacene, Heather, Koo, Phillip J., Kopka, Klaus, Krause, Bernd J., Lindenberg, Liza, Marcus, Charles, Mottaghy, Felix M., Oprea-Lager, Daniela E., Osborne, Joseph R., Piert, Morand, Rowe, Steven P., Schöder, Heiko, Wan, Simon, Wester, Hans-Jürgen, Hope, Thomas A., Herrmann, Ken
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.04.2023
Subjects
Online AccessGet full text
ISSN1619-7070
1619-7089
1619-7089
DOI10.1007/s00259-022-06089-w

Cover

More Information
Summary:Here we aim to provide updated guidance and standards for the indication, acquisition, and interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics are reported for a variety of available PSMA small radioligands. Different scenarios for the clinical use of PSMA-ligand PET/CT are discussed. This document provides clinicians and technicians with the best available evidence, to support the implementation of PSMA PET/CT imaging in research and routine practice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1619-7070
1619-7089
1619-7089
DOI:10.1007/s00259-022-06089-w